Risk stratification of individuals with a germline CDKN2A pathogenic variant
Lumír Kunovský, shared a post by Sara Nikolić, GI fellow at UKC Maribor, on X, adding:
“November is Pancreatic cancer awarness month. Risk stratification of individuals with a germline CDKN2A pathogenic variant
Thanks for sharing Sara.
What’s New.
1 in 4 individuals with a germline CDKN2A pathogenic variant are expected to develop pancreatic cancer in their lifetime
Only in UEGJ.
Cumulative incidence of pancreatic ductal adenocarcinoma (PDAC; red) or death from other causes (blue).
Only in UEGJ.”
Quoting Sara Nikolić‘s post:
“Despite surveillance in carriers of a mutation CDKN2A, late stage and interval pancreatic cancer still occur
High risk:
– 1st-degree Pregnancy with PDAC
– Smoke history
Current model not reliable for clinical practice. Biomarkers.”
Authors: Derk C. F. Klatte, Jihane Meziani, Djuna L. Cahen, Merel van Diepen, Marco J. Bruno, Monique E. van Leerdam, the Dutch Pancreatic Cancer Surveillance Group
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023